News
5d
Clinical Trials Arena on MSNEmory begins enrolment for BioCardia’s trial of ischemic heart failure therapyThe trial is assessing the therapy for individuals with ischemic heart failure of minimised ejection fraction.
At the Atlanta Science Festival in March, Dr. Jaap de Roode discussed his book, "Doctors by Nature: How Ants, Apes & Other ...
For the third straight year, the U.S. News & World Report (USNWR) ranked Emory University’s Nell Hodgson Woodruff School of Nursing master’s program as No. 1. On April 8, USNWR released its rankings ...
CardiAMP HF II is Evaluating the CardiAMPâ„¢ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction ...
More than 100 new doctors just finished their training at Emory University School of Medicine and they’ve now learned where they’re heading for the next step of their education. Friday was ...
BioCardia (BCDA) announced that Emory University School of Medicine in Atlanta Georgia is now enrolling patients with ischemic heart failure in ...
After an earlier trial showed patients with elevated levels of a cardiac stress marker benefited from its cell therapy, the firm shifted focus to this subset.
Emory University confers degrees through various schools, such as: the Goizueta Business School, the School of Law, the School of Medicine, and the Nell Hodgson Woodruff School of Nursing.
Emory University (Woodruff) is a private school. The Nell Hodgson Woodruff School of Nursing has an application fee of $50 for U.S. residents. Tuition for the master's program at the Nell Hodgson ...
Department of Medicine, Emory University School of Medicine, and Co-Director of the Emory Clinical Cardiovascular Research Institute to Serve as Principal Investigator SUNNYVALE, Calif., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results